Short answer
LifeStance Health Group, Inc. (LFST) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $403M (up 21.2% year over year) with net income of $14M.
Q1 2026 key financials · XBRL
- Revenue
- $403M
- +21.2% YoY
- Net income
- $14M
- +1908.9% YoY
- Operating margin
- 5.5%
Source: XBRL data from the LifeStance Health Group, Inc. (LFST) Q1 2026 10-Q on SEC EDGAR. USD.
LifeStance Health Group, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New governance risk: Loss of “controlled company” status triggered Nasdaq independent-committee requirements, fully effective within one year
- Most material ownership risk: TPG and Summit collectively owned approximately 43.6%, enabling influence over board composition and change-of-control decisions
- Regulatory compliance risk: One-year Nasdaq transition period permits exemptions from certain governance protections
- Strategic conflict risk: Principal Stockholders may invest in competing healthcare businesses or pursue acquisitions unavailable to LifeStance
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LifeStance Health Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.